Resources

D-PLEX100, a novel doxycycline formulation that provides high, local concentrations of antibiotic activity for 30 days to reduce surgical site infections

A prospective, randomized assessment of a novel, local antibiotic releasing platform for the prevention of superficial and deep surgical site infections

Reduction in Surgical Site Infections by Localized Administration with D-PLEX100 in Patients with Multiple Risk Factors Undergoing Colorectal Surgery

Reduction in local tumor recurrence in a murine R2 resection model comparing locally administered docetaxel-releasing product, OncoPLEX, versus systemic docetaxel

Incisional microenvironments and reduction in SSIs in patients treated with a local doxycycline-eluting formulation

From Bench to Bedside: D-PLEX limits AMR occurrence in randomized double-blind phase 2 trial in colorectal surgery patients

D-PLEX100, a novel doxycycline formulation that provides high, local concentrations of antibiotic activity for approximately four weeks to reduce Surgical Site Infections

Incisional microenvironments and reduction in SSIs in patients treated with a local doxycycline-eluting formulation

Local prolonged release of antibiotic for prevention of sternal wound infections postcardiac surgery-A novel technology

D-PLEX100 in an Abdominal Surgery Incision Model in Miniature Swine: Safety Study